Vitamin D supplementation can improve velocity of growth in children with vitamin D deficiency which are in treatment with RHGH for growth hormone deficiency

2015 ◽  
Author(s):  
Corina Galesanu ◽  
Ilinka Grozavu ◽  
Florescu A Alexandru
2019 ◽  
Vol 2019 ◽  
pp. 1-8
Author(s):  
Dorota Wójcik ◽  
Leszek Szalewski ◽  
Elżbieta Pietryka-Michałowska ◽  
Janusz Borowicz ◽  
Elżbieta Pels ◽  
...  

Vitamin D deficiency is a common risk factor for multifactorial diseases, and it seems to be associated with growth hormone deficiency (GHD). Vitamin D could prevent dental caries. The goal of this study was to identify whether there is an association between hormonal therapy with growth hormone (GH), vitamin D3 supplementation, vitamin D3 levels, and the occurrence of caries among children affected by GHD. The study group consisted of patients from the Department of Endocrinology and Diabetology of the University Paediatric Hospital at the Medical University of Lublin treated with recombinant human GH for pituitary GHD. It was conducted between October 2014 and June 2015. The study group included 121 children and adolescents aged 6 to 18 years, with 56 children from rural areas and 65 from urban areas. The study group was stratified by the area of residence. We found the statistically significant impact of vitamin D3 concentration on the average value of the DMFT (decayed, missed, and filled teeth) index and its component—DT (decayed teeth), which was noted in subjects from rural areas. Among patients from urban areas, we found a statistically significant correlation between duration of therapy and the DMFT index. An increase in duration of GH therapy by 10 months leads to a mean increase in DMFT index by 0.70. Based on multiple regression analysis, we developed the following model: value of DT = 3.10 − 0.73∗category of vitamin D3 concentration − 0.07∗duration of supplementation (in months). In this model, variables with a significant impact on the value of DT in the group of patients from rural areas include time of vitamin D3 supplementation and category of vitamin D3 concentration. Greater emphasis should be placed on promoting vitamin D3 as a potentially effective agent reducing the number of dental caries, especially among patients with GHD.


2020 ◽  
Vol 43 (10) ◽  
pp. 1485-1492
Author(s):  
T. Durá-Travé ◽  
F. Gallinas-Victoriano ◽  
P. Moreno-González ◽  
M. Urretavizcaya-Martinez ◽  
S. Berrade-Zubiri ◽  
...  

Endocrine ◽  
2015 ◽  
Vol 52 (1) ◽  
pp. 111-119 ◽  
Author(s):  
Maria Cristina Savanelli ◽  
Elisabetta Scarano ◽  
Giovanna Muscogiuri ◽  
Luigi Barrea ◽  
Laura Vuolo ◽  
...  

Endocrine ◽  
2016 ◽  
Vol 53 (2) ◽  
pp. 619-620 ◽  
Author(s):  
Louise Purtell ◽  
Alexander Viardot ◽  
Lesley V. Campbell

2018 ◽  
Vol 66 (5) ◽  
pp. 1.2-8 ◽  
Author(s):  
Rasha Tarif Hamza ◽  
Amira I Hamed ◽  
Mahmoud T Sallam

Few studies, and with controversial results, analyzed vitamin D status in children before and after growth hormone (GH) treatment. Thus, we aimed to assess vitamin D status in prepubertal children with idiopathic growth hormone deficiency (GHD), and to evaluate the effect of GHD and GH treatment on vitamin D levels. Fifty prepubertal children with isolated GHD were compared with 50 controls. All were subjected to history, anthropometric assessment and measurement of 25 hydroxyvitamin D (25(OH)D), serum calcium, phosphorous, alkaline phosphatase and parathyroid hormone (PTH) at diagnosis and 1 year after GH therapy. Serum 25(OH)D levels <30 ng/mL and 20 ng/mL were defined as vitamin D insufficiency and deficiency, respectively. 25(OH)D was lower in cases than controls. Forty per cent of children with GHD were 25(OH)D insufficient and 44% deficient, while 16% were sufficient at baseline. There was a positive correlation between 25(OH)D and peak GH levels. Peak GH was a significant predictor of 25(OH)D levels. After 1 year of GH therapy, 25(OH)D increased (18.42±5.41 vs 34.5±10.1 ng/mL; P<0.001). Overall, 22% of cases remained insufficient and 24% deficient, with an increase in prevalence of children with normal levels (54%; P<0.001). 25(OH) correlated negatively with PTH (r=−0.71, P=0.01). In conclusion, hypovitaminosis D is prevalent in children with GHD and significantly improved 1 year after GH therapy. 25(OH)D should be assessed in children with GHD at diagnosis and during follow-up.


2016 ◽  
Author(s):  
Ivayla Uzunova ◽  
Georgi Kirilov ◽  
Sabina Zacharieva ◽  
Krassimir Kalinov

Sign in / Sign up

Export Citation Format

Share Document